Table 6.
Flavones | Model/Psoriasis Inducer | Activities | Ref. |
---|---|---|---|
Luteolin | NHEKs and HaCaT cells | Inhibits mRNA expression of IL-8 and IL-6; reduces mRNA expression of NFKB1 and RELA and HaCaT cell proliferation | [120] |
HaCaT cells | Inhibits transcriptional expression of HSP90β and HSP90α; decreases exosomes amount | [121] | |
BALB/c mice/ imiquimod |
Reduces psoriatic area, PASI, histological damage, and HSP90β and HSP90α expression; decreases the proportion of Th17/Treg cells and Th1/Th2 | ||
Raw264.7 macrophages |
Decreases both mRNA and protein levels of TNF-α, IL-1β, IL-6, IL-23, and IL-17A; inhibits NF-κB p65 and COX-2 expression; suppresses iNOS and NO | [39] | |
BALB/c mice/ imiquimod |
Reduces PASI, infiltration of macrophage, T cells, and neutrophil, and IL-1β, IL-17A, IL-23, and IL-6 expression | ||
Luteolin-7-glucoside | HEKn | Modifies cell cycle, energy, fatty acid, and redox metabolism; increases KRT10 expression and cortisol levels; decreases PGE2 level | [122] |
C57BL/6 mice/imiquimod | Reduces skin psoriasis-like lesions, Ki67 and p63; increases KRT10, TGase-1, and Loricrin; modulates expression of STAT3 | ||
Baicalein | HaCaT cells | Inhibits cell growth; causes growth arrest in G0/G1phase; induces morphological differentiation Ca2+ dependent; increases KRT10 and KRT1 expression and ERK phosphorylation; activates TRPV4 | [123] |
Baicalin | BALB/c and ICR mice/DNFB | Reduces psoriatic symptoms, edema, and inflammatory cell infiltration; increases orthokeratosis | [124] |
BALB/c mice/imiquimod | Reduces psoriatic symptoms, PASI, histological damage, expression of TNF-α, IL-23, IL-22, and IL-17A, and γδT cells infiltration | [116] | |
Chrysin | NHEKs | Attenuates phosphorylation of JNK, ERK, and p38 kinase; decreases p-STAT3 and p-JAK2; suppresses CCL20 and AMPs expression | [35] |
BALB/c mice/imiquimod | Reduces psoriatic symptoms, PASI, histological damage, TEWL, erythema, blood flow, and thickness; increases the content of surface skin hydration | ||
Tangeretin | HaCaT cells | Inhibits the nuclear translocation of NF-κB p65 and HIF-1α | [125] |
BALB/c mice/PMA-induced ear inflammation | Reduces psoriatic symptoms, histological damage, PMA-induced hyperplasia; down-regulates the production of IL-1β, IL-6, IL-4, TNF-α, IFN-γ, PGE2, COX-2, MIP-2, MCP-1, KC, TRX, nNOS, iNOS, eNOS, MMP-9, MMP-2, TLR4, VEGF, p-Akt, p-p38, p-JNK, p-ERK1/2, NF-κB p65, NF-κB p50, IκBα, IKK-γ, and HIF-1α; suppresses MDA, and NO expression; increases SOD-2, HO-1, and CAT expression |